Megan Dzhumakeev

Patient Safety and Quality Healthcare: Improving Price Transparency in Labs and Beyond with Avalon CEO Bill Kerr, MD

News /

Kerr Shares Solutions to Cost Transparency Roadblocks in Patient Safety and Quality Healthcare Interview There is a transparency issue in the laboratory industry. Although regulations have been developed to improve pricing transparency, there are still some challenges that need to be addressed. Factors such as unwilling participants, site of service differentials, and a lack of […]

Patient Safety and Quality Healthcare: Improving Price Transparency in Labs and Beyond with Avalon CEO Bill Kerr, MD Read More »

Avalon’s Pamela Stahl and Dr. Julie Schulz Featured on the HITea with Grace Podcast

News /

Pamela Stahl and Dr. Julie Schulz Spill the Tea on Price Transparency in Clinical Lab Testing In a recent feature, Avalon President Pamela Stahl and Vice President of Product Dr. Julie Schulz join the HITea with Grace podcast to discuss the importance of price transparency for clinical lab tests, explain the varying costs of lab

Avalon’s Pamela Stahl and Dr. Julie Schulz Featured on the HITea with Grace Podcast Read More »

the_price_of_inaction_uncovering_key_drivers_of_avoidable_ckd_costs_thumbnail

The Price of Inaction: Uncovering 3 Key Drivers of Avoidable CKD Costs

Education & Insights /

Chronic Kidney Disease (CKD) care is a significant cost driver for commercial insurance and Medicare, costing $124.5 billion for Medicare. Additionally, the cost of care exponentially increases with advancing stages of CKD. These costs can be avoided with better quality care and aligned physician incentives. Avalon’s Lab Values Management approach addresses three key drivers to

The Price of Inaction: Uncovering 3 Key Drivers of Avoidable CKD Costs Read More »

avalonselect_genetic_network_march_2024_thumbnail

The AvalonSelect Genetic Network

Education & Insights /

The Value of AvalonSelect Genetic Network The market for genetic tests is growing rapidly and is projected to double by 2025. Ensuring access to quality testing while controlling costs has become increasingly complex and resource-intensive. The AvalonSelect Genetic Network, a select group of preferred genetic labs coupled with robust consultative services, can help health plans

The AvalonSelect Genetic Network Read More »

avalon_medical_specialtyrx_summary_thumbnial

The Avalon Specialty Pharmacy Solution

Education & Insights /

How Avalon Can Support Health Plan’s Medical SpecialtyRx As a collaborative partner, we help our clients configure and translate medical drug policies into rules that address non-adherent utilization and drive medical cost savings. Leveraging Avalon’s expertise in policy development and editing coupled with our proprietary automated policy enforcement technology maximizes time to value and ROI

The Avalon Specialty Pharmacy Solution Read More »

First Report Managed Care: How Lab Values Can Close the Gap Between Patients with Undiagnosed and Under-Staged Chronic Kidney Disease

News /

Dr. Julie Schulz Discusses How a Regional Plan Used Lab Value Insights to Detect and Treat CKD Patients Earlier Chronic kidney disease (CKD) is an insidious condition with devastating consequences when detected and treated too late. While primary care physicians usually make the initial diagnosis, regular screening is not routine for the general population, and

First Report Managed Care: How Lab Values Can Close the Gap Between Patients with Undiagnosed and Under-Staged Chronic Kidney Disease Read More »

In the news

Laboratory Economics features Avalon EVP, Network Solutions, Mike Snyder

News /

Laboratory Economics features Avalon EVP, Network Solutions, Mike Snyder From the March 2024 edition: Avalon Healthcare Solutions (Tampa, FL) is launching the AvalonSelect Genetic Network (ASGN), which will allow health plans to outsource the management of genetic test pricing, utilization and new test evaluation to Avalon. There are more than 175,000 genetic tests currently available

Laboratory Economics features Avalon EVP, Network Solutions, Mike Snyder Read More »

pgtm_ebook_thumbnail

eBook: Transforming the Management of Genetic Testing – Chapter 2

Education & Insights /

Chapter 2: How To Manage Genetic Testing As the genetic testing market continues to grow exponentially in size and cost, the challenge of determining which genetic tests may produce results that effectively guide treatment decisions is becoming increasingly difficult for health plans lacking the expertise and technology to efficiently manage utilization and lab spending. In

eBook: Transforming the Management of Genetic Testing – Chapter 2 Read More »

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

News /

New Testing Network Benefits Plans, Providers, and Members TAMPA, Fla., March 12, 2024 – Health plans overwhelmed by the explosive growth in genetic testing now have a way to manage the tests that ensure quality, decrease costs, and reduce administrative burden. AvalonSelect Genetic Network from Avalon Healthcare Solutions, the world’s first lab insights company, is

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing Read More »